Authors and Disclosures
C. Prost-Squarcioni1,2,3, F. Caux1, E. Schmidt4, M.F. Jonkman5, S. Vassileva6, S.C. Kim7, P. Iranzo8, M. Daneshpazhooh9, J. Terra5, J. Bauer10, J. Fairley11, R. Hall12, M. Hertl13, J.S. Lehman14, B. Marinovic15, A. Patsatsi16, D. Zillikens4, the International Bullous Diseases Group, V. Werth17, D.T. Woodley18 and D.F. Murrell19
1Department of Dermatology and Referral Center for Autoimmune Bullous Diseases; and 3Department of Pathology, APHP, Avicenne Hospital, Bobigny, France
2Department of Histology, UFR Léonard de Vinci, University Paris 13, Bobigny, France
4Department of Dermatology, University of Lübeck, Lübeck, Germany
5Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
6Department of Dermatology, Medical University of Sofia, Sofia, Bulgaria
7Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea
8Department of Dermatology, Hospital Clinic de Barcelona, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
9Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
10Division of Molecular Dermatology, Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria
11Department of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center, Iowa City, IA, U.S.A.
12Department of Dermatology, Duke Medical Center, Durham, NC, U.S.A.
13Department of Dermatology, University Hospital, Marburg, Germany
14Department of Dermatology, Mayo Clinic, Rochester, MN, U.S.A.
15Department of Dermatology and Venereology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia
16Second University Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
17Department of Dermatology, University of Pennsylvania and Philadelphia Department of Veterans Affairs Medical Center, Philadelphia, PA, U.S.A.
18Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, U.S.A.
19Department of Dermatology at St George Hospital, University of New South Wales, Sydney, Australia
Correspondence
Catherine Prost-Squarcioni. E-mail: catherine.prost@aphp.fr
Conflicts of interest
E.S. and D.Z. have received honoraria for lectures from Roche and Fresenius Medical Care, and funding for research and development projects from Euroimmun (E.S., D.Z.), Fresenius Medical Care (D.Z.), Biotest (D.Z.) and Novartis (E.S.). M.H. has received honoraria for participation on advisory boards from Roche, Janssen, Biogen and Novartis, and grants from Biotest, Fresenius and Topas. D.T.W. holds patents with the University of Southern California Stevens Institute on various forms of human recombinant type VII collagen, has received grants for epidermolysis bullosa acquisita and type VII collagen research from the National Institutes of Health, Lotus Tissue Repair and Shire Pharmaceuticals, and has been a consultant for Biofusion, Lotus Tissue Repair and Shire Pharmaceuticals. R.J.F. (co-author) receives fees for consulting from Roche. S.Y. (co-author) received Principal Investigator fees from Roche.